Back

Vasodilator challenge with levosimendan as alternative to nitric oxide in advanced heart failure heart transplant candidates

1 September 2019 (12:21 - 12:30)
Organised by:
Congress Presentation Part of: New treatment studies in heart failure Haemodynamics of Heart Failure ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Marta Tavares-Silva

Faculty of Medicine University of Porto, Porto (Portugal)

8 More presentations in this session

Presentation thumbnail
Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial
Doctor D. Fouassier (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction
Doctor J. Cheng (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial
Doctor H. Kihara (Asahikawa, JP)
Abstract Slides Video
Presentation thumbnail
Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis
Associate Professor A. Kalogeropoulos (Stony Brook, US)
Presentation thumbnail
Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
Mr M. Godet (Rouen, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New treatment studies in heart failure

The Event

Event poster

ESC Congress 2019

1 September 2019 12:21 CET
You may be interested in
thumbnail
Congress Presentation
From hypertension to heart failure: pathophysiology
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Presentation
Renal arterial and venous doppler phenotypes in acute heart failure: insight into diastolic renal perfusion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources